Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122044 · ClinicalTrials.gov registry record · Phase 2
Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
A Phase 2 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00122044 is a Phase 2 study that has completed, run by University of Southern California. The registered enrollment target is 35 participants.
The verdict
NCT00122044, a Phase 2 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is an open-label trial of trihexyphenidyl in children with upper extremity dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to 0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of upper extremity function.
Interventions
- DRUG trihexyphenidyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2003-01 |
| Est. Completion | 2004-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00122044
The ClinicalTrials.gov registry entry for NCT00122044 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which trihexyphenidyl is the first listed.
NCT00122044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00122044 about?
NCT00122044 is a clinical study titled "Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects". This study is an open-label trial of trihexyphenidyl in children with upper extremity dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to 0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of upper extremity function.
What is the current status of trial NCT00122044?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2003-01. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00122044?
The interventions under investigation include: trihexyphenidyl (DRUG).
Who is sponsoring clinical trial NCT00122044?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.